Copyright
©The Author(s) 2022.
World J Clin Cases. May 16, 2022; 10(14): 4380-4394
Published online May 16, 2022. doi: 10.12998/wjcc.v10.i14.4380
Published online May 16, 2022. doi: 10.12998/wjcc.v10.i14.4380
Table 7 Kaplan–Meier analysis of postoperative survival of patients with multiple myeloma bone disease (univariate survival analysis)
Characteristic | Chi-square | P value |
Gender | 1.703 | 0.192 |
ISS stage | 1.966 | 0.374 |
Number of lesions | 7.055 | 0.029a |
Site of lesion | 8.160 | 0.017a |
Isotype | 1.526 | 0.676 |
Preoperative chemotherapy | 0.387 | 0.534 |
Postoperative chemotherapy | 35.837 | 0.000a |
Preoperative radiotherapy | 0.908 | 0.341 |
Time from a diagnosis to surgery | 1.841 | 0.606 |
Operation scheme | 3.583 | 0.167 |
Stem cell transplantation | 2.836 | 0.092 |
Preoperative peripheral blood NLR ≥ 3 | 22.192 | 0.000a |
Preoperative nutrition | 0.782 | 0.676 |
Preoperative performance status | 20.775 | 0.000a |
Preoperative MM activity | 1.634 | 0.652 |
- Citation: Xu ZY, Yao XC, Shi XJ, Du XR. Significance of preoperative peripheral blood neutrophil-lymphocyte ratio in predicting postoperative survival in patients with multiple myeloma bone disease. World J Clin Cases 2022; 10(14): 4380-4394
- URL: https://www.wjgnet.com/2307-8960/full/v10/i14/4380.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i14.4380